September 3, 2026 Bonus Content: Ultragenyx Falls Nearly 47% on Failed Angelman Trial. Its Next FDA Decision...
Newsletters
September 2, 2026 Four weeks from its Oct. 1 report, NKE options imply a move below what...
September 2, 2026 Bonus Content: Five Below Reports Tonight. The Stock Already Knows How to Punish a...
September 2, 2026 Bonus Content: HPE Reports Wednesday. A 1-Cent EPS Gap Is the Whole Story. A...
September 1, 2026 Musk and Zuckerberg framed AI as an economic multiplier at Chapel Hill. The power...
September 1, 2026 DO NO invest in OpenAI and Anthropic’s IPOs. Bonus Content: AVGO’s Sept. 2 Earnings:...
September 1, 2026 My 7-point options checklist Bonus Content: PANW’s 32% Quarter Has an Asterisk A note...
August 31, 2026 26 Pharma Firms Signed MFN Deals. Who Gave Up the Most? With 26 companies...
August 31, 2026 Bonus Content: DKS Dropped 31%. Now the Premium Is the Trade. A note from...
August 31, 2026 $1,000 into $556,454. Impossible? Bonus Content: SNOW’s $0.45 Problem A note from our friends...
